stockrowTransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
Follow TMDX
Alert me
TransMedics Group, Inc. (TMDX) Current ratio
TransMedics Group, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 4.5×, down 2.6× from fiscal 2025 (7.1×). Over the past ten years it has ranged from 2.8× (fiscal 2018) to 12.4× (fiscal 2020); the current reading is higher than 56% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 7.1× | (13.95%) |
| FY2024 | 8.3× | (10.72%) |
| FY2023 | 9.3× | (12.82%) |
| FY2022 | 10.7× | 108.74% |
| FY2021 | 5.1× | (58.66%) |
| FY2020 | 12.4× | 99.10% |
| FY2019 | 6.2× | 123.88% |
| FY2018 | 2.8× | (11.24%) |
| FY2017 | 3.1× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 4.5× | (31.62%) |
| Jun 2026 | 6.6× | (1.67%) |
| Mar 2026 | 6.7× | (5.66%) |
| Dec 2025 | 7.1× | (7.12%) |
| 28 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| AXGN AxoGen, Inc. compare | 12.0× |
| ALMR Alamar Biosciences, Inc. compare | 9.5× |
| INSP Inspire Medical Systems, Inc. compare | 6.4× |
| TMDX TransMedics Group, Inc. | 4.5× |
| NEOG Neogen Corporation compare | 3.9× |
| ESTA Establishment Labs Holdings Inc. compare | 3.8× |
| BFLY Butterfly Network, Inc. compare | 3.6× |
| UFPT UFP Technologies, Inc. compare | 3.0× |
| NVCR NovoCure Limited compare | 2.5× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on TMDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement